The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
AusPAR: Cosentyx
Australian Public Assessment Report
Device/Product Name
Cosentyx
Active ingredients
Secukinumab
AusPAR Date
Published
Submission Number
PM-2021-01700-1-1
Submission Type
Major variation (change in dose regimen)
Decision
Approved